174 related articles for article (PubMed ID: 12015646)
1. [Postoperative haemorrhagia in a girl with congenital factor XI deficiency - successful treatment with desmopressin (DDAVP, Minirin(R))].
Heim MU; Lutze G; Aumann V; Schumacher J; Freigang B
Klin Padiatr; 2002; 214(3):128-31. PubMed ID: 12015646
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic use of desmopressin in surgery of six patients with symptomatic heterozygous factor XI deficiency.
Franchini M; de Gironcoli M; Lippi G; Manzato F; Aprili G; Gandini G
Haematologica; 2000 Jan; 85(1):106-7. PubMed ID: 10629606
[No Abstract] [Full Text] [Related]
3. Desmopressin (DDAVP) for treatment of disorders of hemostasis.
Mannucci PM
Prog Hemost Thromb; 1986; 8():19-45. PubMed ID: 3104987
[TBL] [Abstract][Full Text] [Related]
4. [Familial study of factor XI deficiency. Presurgical prophylactic treatment with desmopressin plus antifibrinolytics].
García Fernández JR; Sánchez Forte M; Diego Fernández Pd; López Berenguel F; Moreno Madrid F
An Esp Pediatr; 2002 Oct; 57(4):373-7. PubMed ID: 12392675
[TBL] [Abstract][Full Text] [Related]
5. The use of desmopressin in congenital factor XI deficiency: a systematic review.
Franchini M; Manzato F; Salvagno GL; Montagnana M; Lippi G
Ann Hematol; 2009 Oct; 88(10):931-5. PubMed ID: 19609524
[TBL] [Abstract][Full Text] [Related]
6. Review: Factor XI deficiency: review and management in pregnant women.
Martín-Salces M; Jimenez-Yuste V; Alvarez MT; Quintana M; Hernández-Navarro F
Clin Appl Thromb Hemost; 2010 Apr; 16(2):209-13. PubMed ID: 19049995
[TBL] [Abstract][Full Text] [Related]
7. Response to desmopressin of factors XI, X and V in patients with factor VIII deficiency and von Willebrand disease.
White B; Lawler P; Riddell A; Nitu-Whalley IC; Hermans C; Lee CA; Brown SA
Br J Haematol; 2004 Jul; 126(1):100-4. PubMed ID: 15198739
[TBL] [Abstract][Full Text] [Related]
8. Response of patients with hemophilia A and von Willebrand disease to desmopressin (DDAVP).
Santiago-Borrero PJ; Casanova R
Bol Asoc Med P R; 1990 May; 82(5):207-10. PubMed ID: 2115785
[TBL] [Abstract][Full Text] [Related]
9. Combined factor VIII and factor XI congenital deficiency: a case report.
De Angelis V; Orazi BM; Santarossa L; Molaro G
Haematologica; 1990; 75(3):272-3. PubMed ID: 2227624
[TBL] [Abstract][Full Text] [Related]
10. The effect of combined factor XI deficiency with von Willebrand factor abnormalities on haemorrhagic diathesis.
Tavori S; Brenner B; Tatarsky I
Thromb Haemost; 1990 Feb; 63(1):36-8. PubMed ID: 2111046
[TBL] [Abstract][Full Text] [Related]
11. [Subcutaneous injection of desmopressin (DDAVP) for increasing factor VIII and von Willebrand factor in plasmapheresis].
Köhler M; Kotitschke R; Braun B; Hellstern P; Mörsdorf S; Pindur G; Heiden M; Wenzel E
Beitr Infusionsther; 1990; 26():136-41. PubMed ID: 1703813
[TBL] [Abstract][Full Text] [Related]
12. Acquired von Willebrand disease--hemostatic management of major orthopedic surgery with high-dose immunoglobulin, desmopressin, and continuous factor concentrate infusion.
Frank RD; Kunz D; Wirtz DC
Am J Hematol; 2002 May; 70(1):64-71. PubMed ID: 11994985
[TBL] [Abstract][Full Text] [Related]
13. A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease.
Jilma B; Paulinska P; Jilma-Stohlawetz P; Gilbert JC; Hutabarat R; Knöbl P
Thromb Haemost; 2010 Sep; 104(3):563-70. PubMed ID: 20589313
[TBL] [Abstract][Full Text] [Related]
14. Retrospective review of the management of elective surgery with desmopressin and clotting factor concentrates in patients with von Willebrand disease.
Nitu-Whalley IC; Griffioen A; Harrington C; Lee CA
Am J Hematol; 2001 Apr; 66(4):280-4. PubMed ID: 11279640
[TBL] [Abstract][Full Text] [Related]
15. [Isolated increased aPTT with anamnestic hemorrhagic diathesis--severe FXI deficiency].
Redondo M; Solenthaler M; Zeerleder S; Wuillemin WA
Ther Umsch; 1999 Sep; 56(9):502-4. PubMed ID: 10517119
[TBL] [Abstract][Full Text] [Related]
16. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
[TBL] [Abstract][Full Text] [Related]
17. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.
Michiels JJ; van Vliet HH; Berneman Z; Schroyens W; Gadisseur A
Acta Haematol; 2009; 121(2-3):167-76. PubMed ID: 19506363
[TBL] [Abstract][Full Text] [Related]
18. Management of gynecologic surgery in the patient with factor XI deficiency: a review of the literature.
Steward RG; Saleh OA; James AH; Shah AA; Price TM
Obstet Gynecol Surv; 2012 May; 67(5):291-7. PubMed ID: 22624777
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the clinical safety of desmopressin during pregnancy in women with a low plasmatic von Willebrand factor level and bleeding history.
Sánchez-Luceros A; Meschengieser SS; Turdó K; Arizó A; Woods AI; Casais P; Blanco AN; Kempfer AC; Lazzari MA
Thromb Res; 2007; 120(3):387-90. PubMed ID: 17056101
[No Abstract] [Full Text] [Related]
20. Biological and clinical response to desmopressin (DDAVP) in a retrospective cohort study of children with low von Willebrand factor levels and bleeding history.
Sánchez-Luceros A; Meschengieser SS; Woods AI; Chuit R; Turdó K; Blanco A; Lazzari MA
Thromb Haemost; 2010 Nov; 104(5):984-9. PubMed ID: 20886181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
